AKESFAkeso Inc

$12.10
$1.00
(7.63%)
Today
Updated: 09:39 AM EDT
EarningsAug 26
Mkt Cap$12.05B
Vol2,287.00
News
all
press releases
News Placeholder
Summit Draws Frenzied Retail Chatter After Akeso Drug Shows Survival Benefit In Lung Cancer; Retail Sees More Upside
Analysts at Bernstein called the survival data “a positive surprise,” framing it as Akeso’s biggest catalyst since the drug previously outperformed Merck’s top-selling cancer therapy.
Stocktwits
<
...
1
>

Advertisement|Remove ads.